menu toggle
Friday, November 28
Our offices will also be closed on Friday, November 28. While some deliveries will take place on Friday according to network operations, our Customer Service and Customer Systems Support teams will be unavailable. Please review our full holiday schedule for more detailed information and to plan your orders accordingly.
View full holiday schedule
Action required: New logo and email address for invoices starting October 18
Ensure that you’re prepared to continue receiving invoices electronically.
Learn more

July 8, 2020

Now Available ONTRUZANT®

ONTRUZANT® is a HER2/neu receptor antagonist indicated for:
  • The treatment of HER2-overexpressing breast cancer.
  • The treatment of HER2-overexpressing metastatic gastric or gastroesophageal junction adenocarcinoma. HER2-overexpressing breast cancer.

Please see the Full Prescribing Information.

More Company News

News

Now available WAYRILZ™

November 2025

News

Now available ENSACOVE™

November 2025

News

Now available INLURIYO® 

October 2025